• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Trial Assessment Principles of National Class III Medical Devices in China.中国国家三类医疗器械临床试验评估原则。
Orthop Surg. 2019 Oct;11(5):715-719. doi: 10.1111/os.12498. Epub 2019 Sep 6.
2
Clinical investigation of medical devices.医疗器械的临床研究。
Med Device Technol. 1995 Jun;6(5):36-40.
3
Notified Body guidance on clinical evaluation.公告机构关于临床评价的指南。
Med Device Technol. 2000 Sep;11(7):26-8.
4
[Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].[欧洲创新型高风险医疗器械的引入:临床疗效和安全性有保障吗?]
Rev Epidemiol Sante Publique. 2013 Apr;61(2):105-10. doi: 10.1016/j.respe.2012.08.004. Epub 2013 Mar 7.
5
[Experiences and recommendations of the German Federal Institute for Drugs and Medical Devices (BfArM) concerning clinical investigation of medical devices and the evaluation of serious adverse events (SAE)].德国药品和医疗器械联邦研究所(BfArM)关于医疗器械临床研究及严重不良事件(SAE)评估的经验与建议
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Dec;57(12):1368-75. doi: 10.1007/s00103-014-2060-y.
6
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.2010 年和 2011 年 FDA 上市前批准的高风险治疗性医疗器械全产品生命周期临床试验特点。
JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
7
Technology assessment of medical devices at the Center for Devices and Radiological Health.设备与放射健康中心对医疗设备的技术评估。
Am J Manag Care. 1998 Sep 25;4 Spec No:SP129-35.
8
Medical devices; retention in class III and effective date of requirement for premarket approval for three preamendments class III devices--FDA. Proposed rule; opportunity to request a change in classification.医疗器械;三类器械的保留以及三项修订前的三类器械上市前批准要求的生效日期——美国食品药品监督管理局。拟议规则;请求变更分类的机会。
Fed Regist. 1998 Jul 30;63(146):40673-7.
9
Principles and Benefits of Explicitly Designed Medical Device Safety Architecture.明确设计的医疗设备安全架构的原则和益处。
Biomed Instrum Technol. 2017;51(5):380-389. doi: 10.2345/0899-8205-51.5.380.
10
Regional Draining Lymph Nodes: Considerations for Medical Device Studies.
Toxicol Pathol. 2019 Apr;47(3):339-343. doi: 10.1177/0192623318811075. Epub 2018 Nov 9.

本文引用的文献

1
Review and approval of medical devices in China: Changes and reform.中国医疗器械的审评审批:变革与改革。
J Biomed Mater Res B Appl Biomater. 2018 Aug;106(6):2093-2100. doi: 10.1002/jbm.b.34031. Epub 2017 Oct 28.
2
Informed consent-It's more than a signature on a piece of paper.知情同意——它远不止是在一张纸上签名。
Am J Surg. 2017 Dec;214(6):993-997. doi: 10.1016/j.amjsurg.2017.09.015. Epub 2017 Sep 20.
3
Linking quality indicators to clinical trials: an automated approach.将质量指标与临床试验相联系:一种自动化方法。
Int J Qual Health Care. 2017 Aug 1;29(4):571-578. doi: 10.1093/intqhc/mzx076.
4
Why non-inferiority is more challenging than superiority?为什么非劣效性比优效性更具挑战性?
Mult Scler. 2017 May;23(6):790-791. doi: 10.1177/1352458517703805. Epub 2017 Mar 28.
5
The evolution of informed consent.知情同意的演变
Br J Surg. 2017 Aug;104(9):1119-1120. doi: 10.1002/bjs.10520. Epub 2017 Mar 23.
6
Meta-evaluation of meta-analysis: ten appraisal questions for biologists.Meta分析的Meta评估:生物学家的十个评估问题
BMC Biol. 2017 Mar 3;15(1):18. doi: 10.1186/s12915-017-0357-7.
7
Clinical trial registration was not an indicator for low risk of bias.临床试验注册并非低偏倚风险的指标。
J Clin Epidemiol. 2017 Apr;84:47-53. doi: 10.1016/j.jclinepi.2016.11.011. Epub 2017 Jan 11.
8
Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.头孢洛林对金黄色葡萄球菌体外活性的多中心多方法评价
Diagn Microbiol Infect Dis. 2016 Aug;85(4):452-8. doi: 10.1016/j.diagmicrobio.2016.05.003. Epub 2016 May 8.
9
Medical device market in China.中国的医疗设备市场。
Artif Organs. 2015 Jun;39(6):520-5. doi: 10.1111/aor.12427. Epub 2015 Mar 4.
10
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.拉坦前列素治疗开角型青光眼(英国青光眼治疗研究组):一项随机、多中心、安慰剂对照试验。
Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19.

中国国家三类医疗器械临床试验评估原则。

Clinical Trial Assessment Principles of National Class III Medical Devices in China.

机构信息

Center for Medical Device Evaluation, Center for Medical Device Evaluation NMPA, Beijing, China.

出版信息

Orthop Surg. 2019 Oct;11(5):715-719. doi: 10.1111/os.12498. Epub 2019 Sep 6.

DOI:10.1111/os.12498
PMID:31490619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6819180/
Abstract

Class III medical devices are defined as those which are implanted inside the human body and applied to maintain normal life and retain original tissue or organic functions. Because these devices are associated with high risk, their effectiveness and safety should be strictly monitored and clinically investigated. The aim of clinical investigation of these medical devices is to ensure the acceptability of their effectiveness and safety levels. On designing the clinical trial, the investigator should determine the indices to assess the effectiveness and safety of medical devices, select reasonable data-analyzing methods, and pay attention to several other issues. Although some guidelines on specific class III medical devices have illustrated those aspects in detail, there is still no comprehensive report that details all those principles and methodologies. This article aims to summarize the common features among the instruction principles and provide technological support for the clinical study of class III medical devices.

摘要

III 类医疗器械是指那些植入人体内部、用于维持正常生命和保留原有组织或有机功能的医疗器械。由于这些设备与高风险相关,因此应严格监测和临床研究其有效性和安全性。这些医疗器械的临床研究旨在确保其有效性和安全性水平的可接受性。在设计临床试验时,研究者应确定评估医疗器械有效性和安全性的指标,选择合理的数据分析方法,并注意其他几个问题。虽然一些关于特定 III 类医疗器械的指南详细说明了这些方面,但仍没有全面的报告详细说明所有这些原则和方法。本文旨在总结指令原则中的共同特征,并为 III 类医疗器械的临床研究提供技术支持。